Randomised phase II trial of mFOLFOX6 plus bevacizumab versus mFOLFOX6 plus cetuximab as first-line treatment for colorectal liver metastasis (ATOM trial)Eiji Oki, Yoshihiko Maehara, Kei Muro et al.|British Journal of Cancer|2019Cited by 61
A Multicenter, Phase II Trial of Schedule Modification for Nab-Paclitaxel in Combination with Ramucirumab for Patients with Previously Treated Advanced Gastric or Gastroesophageal Junction Cancer: The B-RAX Trial (JACCRO GC-09)Ryohei Kawabata, Masashi Fujii, Naoki Izawa et al.|Targeted Oncology|2023Cited by 5